FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3029822752> ?p ?o ?g. }

• W3029822752 abstract "e23565 Background: Diffuse Tenosynovial Giant Cell Tumor (d-TGCT) is a rare, locally aggressive neoplasm of joint and tendon sheath synovia, which may severely affect patients (pts) QOL due to pain, limited joint function and destruction of bone and local tissues. This study analyzes real-world data to describe d-TGCT pt journey and QOL in the US. Methods: The TGCT Observational Platform Project (TOPP), the first non-interventional prospective disease registry, enrolled d-TGCT pts at 10 Western European (EU) and 2 US sarcoma centers from Nov 2016 to Mar 2019, with prospective follow-up of 24 mo. Pts demographics, disease history and ongoing medical treatment and pt-reported outcomes (PROs) (pain, stiffness, PROMIS Physical Function [PF] and EQ-5D) were collected at baseline and every 6 mo during follow-up periods. Descriptive analyses from baseline compared US pts with Western EU pts (Table). Results: Of 166 d-TGCT pts, 30 were enrolled in the US. Mean age was 40.6 ± 12.82 y, with 63.3% female and 66.7% with tumor in knee. Median time from first symptom to diagnosis was 12 mo (range; 0–153). 28 pts (93.3%) had surgery, 4 pts (13.3%) had tyrosine kinase inhibitors (TKI), no pts had radiotherapy. 18 pts (60%) experienced >1 locoregional recurrence. Median Pain Severity Score (PSS) and Pain Interference Score (PIS) were 2.8 and 3.0, respectively. Median PROMIS PF Score was 39.8. Mean EQ-5D index score and visual analogue scale (VAS) were 0.73 ±0.229 and 75.5 ±13.31, respectively. Compared with Western EU pts, US pts reported similar PROs and QOL, were younger, had shorter delay in diagnosis, and lower use of systemic therapy or radiotherapy (Table). Conclusions: d-TGCT affects a relatively young population in the US, similar to Western EU, resulting in serious impairment in daily activities and QOL. Shorter diagnostic delay and less frequent use of non–surgical approach was observed in the US. [Table: see text]" @default.
• W3029822752 created "2020-06-05" @default.
• W3029822752 creator A5002439302 @default.
• W3029822752 creator A5010888827 @default.
• W3029822752 creator A5011660165 @default.
• W3029822752 creator A5019288987 @default.
• W3029822752 creator A5031540987 @default.
• W3029822752 creator A5040082039 @default.
• W3029822752 creator A5050635856 @default.
• W3029822752 creator A5057780490 @default.
• W3029822752 creator A5069717147 @default.
• W3029822752 creator A5075630037 @default.
• W3029822752 creator A5076740454 @default.
• W3029822752 creator A5080548972 @default.
• W3029822752 creator A5089410993 @default.
• W3029822752 date "2020-05-20" @default.
• W3029822752 modified "2023-10-18" @default.
• W3029822752 title "Patient journey and quality of life (QOL) among diffuse-type TGCT in the U.S." @default.
• W3029822752 doi "https://doi.org/10.1200/jco.2020.38.15_suppl.e23565" @default.
• W3029822752 hasPublicationYear "2020" @default.
• W3029822752 type Work @default.
• W3029822752 sameAs 3029822752 @default.
• W3029822752 citedByCount "0" @default.
• W3029822752 crossrefType "journal-article" @default.
• W3029822752 hasAuthorship W3029822752A5002439302 @default.
• W3029822752 hasAuthorship W3029822752A5010888827 @default.
• W3029822752 hasAuthorship W3029822752A5011660165 @default.
• W3029822752 hasAuthorship W3029822752A5019288987 @default.
• W3029822752 hasAuthorship W3029822752A5031540987 @default.
• W3029822752 hasAuthorship W3029822752A5040082039 @default.
• W3029822752 hasAuthorship W3029822752A5050635856 @default.
• W3029822752 hasAuthorship W3029822752A5057780490 @default.
• W3029822752 hasAuthorship W3029822752A5069717147 @default.
• W3029822752 hasAuthorship W3029822752A5075630037 @default.
• W3029822752 hasAuthorship W3029822752A5076740454 @default.
• W3029822752 hasAuthorship W3029822752A5080548972 @default.
• W3029822752 hasAuthorship W3029822752A5089410993 @default.
• W3029822752 hasConcept C126322002 @default.
• W3029822752 hasConcept C14184104 @default.
• W3029822752 hasConcept C159110408 @default.
• W3029822752 hasConcept C1862650 @default.
• W3029822752 hasConcept C23131810 @default.
• W3029822752 hasConcept C2779951463 @default.
• W3029822752 hasConcept C71924100 @default.
• W3029822752 hasConceptScore W3029822752C126322002 @default.
• W3029822752 hasConceptScore W3029822752C14184104 @default.
• W3029822752 hasConceptScore W3029822752C159110408 @default.
• W3029822752 hasConceptScore W3029822752C1862650 @default.
• W3029822752 hasConceptScore W3029822752C23131810 @default.
• W3029822752 hasConceptScore W3029822752C2779951463 @default.
• W3029822752 hasConceptScore W3029822752C71924100 @default.
• W3029822752 hasLocation W30298227521 @default.
• W3029822752 hasOpenAccess W3029822752 @default.
• W3029822752 hasPrimaryLocation W30298227521 @default.
• W3029822752 hasRelatedWork W11109016 @default.
• W3029822752 hasRelatedWork W13665836 @default.
• W3029822752 hasRelatedWork W17913474 @default.
• W3029822752 hasRelatedWork W1977508 @default.
• W3029822752 hasRelatedWork W21529740 @default.
• W3029822752 hasRelatedWork W3046699 @default.
• W3029822752 hasRelatedWork W4374720 @default.
• W3029822752 hasRelatedWork W7395253 @default.
• W3029822752 hasRelatedWork W9185232 @default.
• W3029822752 hasRelatedWork W9652795 @default.
• W3029822752 isParatext "false" @default.
• W3029822752 isRetracted "false" @default.
• W3029822752 magId "3029822752" @default.
• W3029822752 workType "article" @default.